Ainoa Ugarte

562 total citations
21 papers, 117 citations indexed

About

Ainoa Ugarte is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ainoa Ugarte has authored 21 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Ainoa Ugarte's work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (7 papers). Ainoa Ugarte is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (7 papers). Ainoa Ugarte collaborates with scholars based in Spain and United Kingdom. Ainoa Ugarte's co-authors include Josep Mallolas, Lorna Leal, Berta Torres, Lorena de la Mora, Iván Chivite, Estebán Martínez, Elisa de Lazzari, Alexy Inciarte, Maria Martínez‐Rebollar and Montserrat Laguno and has published in prestigious journals such as Annals of Surgery, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Ainoa Ugarte

19 papers receiving 114 citations

Peers

Ainoa Ugarte

VIROL

EPIDE

HEPAT

Laura Comi Italy

Robert Zangerle Austria

Christine Cheneau France

Cal Cohen United States

Oon Tek Ng Singapore

Hylke Waalewijn Netherlands

Coca Necsoi Belgium

Supunnee Jirajariyavej Thailand

Vasiliki Chounta United Kingdom

Pedro Cahn Argentina

Laura Comi Italy

Ainoa Ugarte

127 ×1.5

91 ×1.6

VIROL

32 ×0.9

39 ×1.3

EPIDE

14 ×1.3

HEPAT

Citations per year, relative to Ainoa Ugarte Ainoa Ugarte (= 1×) peers Laura Comi

Countries citing papers authored by Ainoa Ugarte

Since Specialization

Citations

This map shows the geographic impact of Ainoa Ugarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ainoa Ugarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ainoa Ugarte more than expected).

Fields of papers citing papers by Ainoa Ugarte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ainoa Ugarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ainoa Ugarte. The network helps show where Ainoa Ugarte may publish in the future.

Co-authorship network of co-authors of Ainoa Ugarte

This figure shows the co-authorship network connecting the top 25 collaborators of Ainoa Ugarte. A scholar is included among the top collaborators of Ainoa Ugarte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ainoa Ugarte. Ainoa Ugarte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sánchez, Carolina, Begoña Espinosa, Emmanuel Coloma, et al.. (2024). Safety and efficiency of discharge to home hospitalization directly after emergency department care of patients with acute heart failure. Emergencias. 35(3). 176–184. 5 indexed citations

Téllez, Adrián, Sara Fernández, Gemma Martínez‐Nadal, et al.. (2024). Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study. Infection. 53(2). 583–592. 1 indexed citations

Ugarte, Ainoa, Lorena de la Mora, Elisa de Lazzari, et al.. (2024). Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study. Journal of Antimicrobial Chemotherapy. 79(9). 2343–2353. 1 indexed citations

Ugarte, Ainoa, David Cucchiari, Laura García, et al.. (2023). Effectiveness and Safety of Postoperative Hospital at Home for Surgical Patients. Annals of Surgery. 279(5). 727–733. 1 indexed citations

Mora, Lorena de la, Ainoa Ugarte, Maria Martínez‐Rebollar, et al.. (2022). Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain. AIDS and Behavior. 26(12). 4055–4062. 10 indexed citations

Mora, Lorena de la, Maria Martínez‐Rebollar, Elisa de Lazzari, et al.. (2022). Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study. Infectious Diseases and Therapy. 11(6). 2111–2124. 8 indexed citations

López, Néstor, Emmanuel Coloma, Celia Cardozo, et al.. (2022). Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience. International Journal of Infectious Diseases. 127. 124–128. 5 indexed citations

Ugarte, Ainoa, Lorena de la Mora, Maria Martínez‐Rebollar, et al.. (2022). Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience. Infectious Diseases and Therapy. 12(2). 425–442. 3 indexed citations

Mora, Lorena de la, Montserrat Laguno, Elisa de Lazzari, et al.. (2022). Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study. Sexuality Research and Social Policy. 20(2). 614–625. 5 indexed citations

10.

Mallolas, Josep & Ainoa Ugarte. (2021). Detectar personas que desconocen su infección por VIH en los servicios de urgencias: ¿una utopía?. Emergencias. 33(4). 249–250. 2 indexed citations

11.

Laguno, Montserrat, Ainoa Ugarte, Maria Martínez‐Rebollar, et al.. (2021). Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora. Enfermedades Infecciosas y Microbiología Clínica. 41(1). 24–28. 2 indexed citations

12.

Laguno, Montserrat, Maria Martínez‐Rebollar, Elisa de Lazzari, et al.. (2021). Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients. Clinical Microbiology and Infection. 28(4). 610.e1–610.e7. 5 indexed citations

13.

Ugarte, Ainoa, Lorena de la Mora, Maria Martínez‐Rebollar, Josep Mallolas, & Montserrat Laguno. (2021). An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis. Antiviral Therapy. 26(1-2). 9–12.

14.

Ugarte, Ainoa & Josep Mallolas. (2021). Detection of unknown cases of human immunodeficiency virus infection in emergency departments: a utopian ideal?. Emergencias. 33(4). 249–250. 1 indexed citations

15.

Ambrosioni, Juan, Alexy Inciarte, Lorena de la Mora, et al.. (2021). Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre. Journal of Antimicrobial Chemotherapy. 77(4). 1133–1139. 41 indexed citations

16.

Torres, Berta, Alba Díaz, Àngels Fabra, et al.. (2021). Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial. HIV Medicine. 22(8). 674–681. 6 indexed citations

17.

Borrell, María, Irene Fernández, Ainoa Ugarte, et al.. (2021). High rates of long‐term progression in HIV‐1‐positive elite controllers. Journal of the International AIDS Society. 24(2). e25675–e25675. 17 indexed citations

18.

Fehér, Csaba, Montserrat Plana, Alberto C. Guardo, et al.. (2020). A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(5). 479–485. 2 indexed citations

19.

Díaz-Brito, Vicens, Beatriz Mothe, Alberto C. Guardo, et al.. (2019). Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B. Vaccines. 7(4). 178–178. 1 indexed citations

20.

Pou-Serradell, A, et al.. (1978). [Intermediate forms of infantile spinal amyotrophy. Apropos of 20 personal observations].. PubMed. 134(1). 35–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact